SIGA Technologies, Inc.
SIGA•NASDAQ•Healthcare•Drug Manufacturers - Specialty & Generic

About SIGA Technologies

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.siga.com
Phone212 672 9100
Address
31 East 62nd Street New York, New York 10065 United States

Corporate Identifiers

CIK0001010086
CUSIP826917106
ISINUS8269171067
EIN13-3864870
SIC2834

Leadership Team & Key Executives

Dr. Diem Nguyen M.B.A., Ph.D.
Chief Executive Officer and Director
Daniel J. Luckshire CPA, M.B.A.
Executive Vice President, Chief Financial Officer and Secretary
Dr. Dennis E. Hruby Ph.D.
Executive Vice President and Chief Scientific Officer
Lawrence R. Miller Esq., J.D.
General Counsel and Corporate Secretary
Tove C. Bolken
Senior Vice President of Operations and Chief Supply Chain Officer
Herb Vloedman
Senior Vice President and Chief Information Officer